Clinical Observation of Intermittent Catheterization Combined with Auricular Point Pressing Therapy for Neurogenic Bladder Following Spinal Cord Injury

Objective: To evaluate the clinical efficacy of intermittent catheterization combined with auricular seed pressure therapy in patients with neurogenic bladder (NB) secondary to spinal cord injury (SCI), and to provide evidence-based guidance for optimizing clinical management strategies. Methods: Seventy patients with NB following SCI who were treated at the Fifth Affiliated Hospital of Jinan University between January 2023 and June 2025 were enrolled in this study. Participants were randomly assigned to either the observation group or the control group using a random number table, with 35 patients in each group. The control group received standard intermittent catheterization alone, whereas the observation group received additional auricular seed pressure therapy in conjunction with the same catheterization regimen. Primary and secondary outcomes—including urinary function parameters, clinical symptom severity, bladder function indices, quality of life (QoL), and overall clinical response rate—were assessed before treatment and after the intervention period. Results: Following treatment, the observation group demonstrated significantly lower daily micturition frequency, fewer episodes of urinary incontinence, and a reduced incidence of urinary tract infections (UTIs), along with a higher average single voided volume compared to the control group (P = 0.021, P = 0.018, P = 0.039, P = 0.024; all P Conclusion: Intermittent catheterization combined with auricular seed pressure therapy significantly improves urinary and bladder function, alleviates clinical symptoms, and enhances overall quality of life in patients with neurogenic bladder secondary to spinal cord injury, demonstrating superior therapeutic efficacy.